top of page

AGTC Genomics and IMU University launch Malaysia’s first micro-credential certification in clinical pharmacogenomics

3 hours ago
2 min read

The six-week online programme uses real patient cases to help healthcare professionals interpret genetic test results and apply them to prescribing decisions.


Professor Chee-Onn Leong, Founder and CEO of AGTC Genomics, discusses adverse drug reactions and how a patient’s genetic profile can help clinicians choose a medicine or adjust a dose during his keynote at the IMU University–AGTC Genomics launch.
Professor Chee-Onn Leong, Founder and CEO of AGTC Genomics, discusses adverse drug reactions and how a patient’s genetic profile can help clinicians choose a medicine or adjust a dose during his keynote at the IMU University–AGTC Genomics launch.

KUALA LUMPUR, 20 November 2026 — AGTC Genomics and IMU University today introduced Pharmacogenomics Essentials: Guiding Safer and Smarter Prescribing at a joint soft launch. The partners describe it as Malaysia’s first industry-integrated micro-credential dedicated to clinical pharmacogenomics. Healthcare professionals who successfully complete the programme will receive a Certificate of Completion jointly issued by IMU University and AGTC Genomics, together with a verifiable digital credential.


Representatives of AGTC Genomics and IMU University mark the soft launch of Pharmacogenomics Essentials: Guiding Safer and Smarter Prescribing, their joint micro-credential for healthcare professionals, in Kuala Lumpur on 20 November 2026.
Representatives of AGTC Genomics and IMU University mark the soft launch of Pharmacogenomics Essentials: Guiding Safer and Smarter Prescribing, their joint micro-credential for healthcare professionals, in Kuala Lumpur on 20 November 2026.

Two patients can take the same dose of a medicine and respond differently. One may benefit, while the other experiences side effects or sees little improvement. Pharmacogenomics studies how inherited differences influence these responses. For certain medicines, a genetic test result can help a care team decide whether to start at a different dose or consider another treatment. That decision also takes account of the patient’s kidney and liver function, other medicines and medical history.


The programme gives doctors, pharmacists and laboratory professionals an opportunity to work through those decisions together. Using anonymised patient reports from oncology, cardiology, psychiatry and pain management, learners practise reading a pharmacogenomics report, identifying which findings matter for the medicine under review and consulting clinical guidelines to determine what action the evidence supports.


The soft launch featured opening remarks by Professor Winnie Chee, Deputy Vice Chancellor, Research and Innovation & Director of the Institute for Research, Development and Innovation, and Professor Chee-Onn Leong, Founder and CEO of AGTC Genomics The event also gave participants a preview of the curriculum and its online learning platform.


Delivered through OpenLearning, the programme comprises 20 hours of learning over six weeks. Its asynchronous format allows working professionals to study around clinical and laboratory schedules. Participants complete quizzes, a case-based assignment and a final assessment. The standard course fee is RM1,200.


For professionals planning to introduce pharmacogenomics in a hospital, clinic or pharmacy, the course also examines what happens after a test is ordered. Learners consider how to assess laboratory quality, make results available in the patient record and communicate a finding to the person responsible for prescribing. By bringing IMU University’s experience in healthcare education together with AGTC Genomics’ clinical laboratory expertise, the partnership gives practitioners a way to build these skills through lifelong learning and put them to use when they next review a patient’s medicines.




About AGTC Genomics


AGTC Genomics is a Malaysian precision medicine tech company with BioNexus status. Its advanced genomics laboratory in Bukit Jalil, Kuala Lumpur, holds accreditation from the College of American Pathologists (CAP), as well as ISO 15189 and ISO/IEC 17025 accreditation. The company provides genomic testing in pharmacogenomics, cancer and rare diseases. Through its collaboration with IMU University, AGTC Genomics brings clinical laboratory experience into professional education, giving healthcare teams the opportunity to practise interpreting the types of reports they encounter in patient care.


 
 
 

Comments


bottom of page